Sivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia-reperfusion injury

Digestive Diseases and Sciences

Volumn 59, Issue 4, 2014, Pages 787-794

  Sakai, Seisho ^a   Tajima, Hidehiro ^a   Miyashita, Tomoharu ^a   Nakanuma, Shin Ichi ^a   Makino, Isamu ^a   Hayashi, Hironori ^a   Nakagawara, Hisatoshi ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Saito, Hidehito ^a   Munesue, Seiichi ^a   Yamamoto, Yasuhiko ^a   Ohta, Tetsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Ischemia reperfusion injury; Liver failure; Neutrophil elastase inhibitor; Sivelestat sodium hydrate; Systemic inflammatory response syndrome

Indexed keywords

LEUKOCYTE ELASTASE INHIBITOR; SIVELESTAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL ADHESION; CELL MIGRATION; LIVER INJURY; LIVER ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLYCINE; IMMUNE SYSTEM DISEASES; LEUKOCYTE DISORDERS; LIVER DISEASES; MALE; NEUTROPHILS; RATS; RATS, WISTAR; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84897472695     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2963-8     Document Type: Article

References (45)

1. Sasaki H, Matsuno T, Ishikawa T, et al. Activation of apoptosis during early phase of reperfusion after liver transplantation. Transpl Proc. 1977;29:406-407.
2. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2007;147:153-159.
3. Olthoff KM. Can reperfusion injury of the liver be prevented? Trying to improve on a good thing. Pediatr Transpl. 2001;5:390-393. (Pubitemid 33095200)
4. Eum HA, Cha YN, Lee SM. Necrosis and apoptosis: sequence of liver damage following reperfusion after 60 min ischemia in rats. Biochem Biophys Res Commun. 2007;358:500-505.
5. Jaeschke H, Farhood A, Smith CW. Nertrophil contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 1990;4:3355-3359. (Pubitemid 120012584)
6. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol. 2003;74:86-93. (Pubitemid 36438656)
7. Teoh NC, Farrell GC. Hepatic ischemia-reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18:891-902. (Pubitemid 37056167)
8. Omar R, Nomikos I, Piccorelli G, Savino J, Agarwal N. Prevention of postischemic lipid peroxidation and liver cell injury by iron chelation. Gut. 1989;30:510-514.
9. Nordstroem G, Seeman T, Hasselgren PO. Beneficial effect of allopurinol in liver ischemia. Surgery. 1985;97:679-683.
10. Zhong Z, Lemasters JJ, Thurman RG. Role of purines and xanthine oxidase in reperfusion injury in per-fused rat liver. J Pharmacol Exp Ther. 1989;250:470-475. (Pubitemid 19216128)
11. Jaeschke H, Smith CV, Mitchell J. R: reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest. 1988;81:1240-1246.
12. Metzger J, Dore SP, Lauterburg B. H: oxidant stress during reperfusion of ischemic liver: no evidence for a role of xanthine oxidase. Hepatology. 1988;8:580-584.
13. Jaeschke H. Chemokines and liver inflammation: the battle between pro- and anti-inflammatory mediators. Hepatology. 1997;25:252-253. (Pubitemid 27015022)
14. Jaeschke H, Smith CW. Mechanisms of neutrophil induced parenchymal cell injury. J Leukoc Biol. 1997;61:647-653. (Pubitemid 27276056)
15. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:1083-1088.
16. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26:912-919. (Pubitemid 44323408)
17. Chosay JG, Essani NA, Dunn CJ, Jaeschke H. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol. 1997;272:195-200.
18. Kawabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991;177:814-820.
19. Jian MY, Koizumi T, Tsushima K, et al. Effects of granulocyte colony-stimulating factor (G-CSF) and neutrophil elastase inhibitor (ONO-5046) on acid-induced lung injury in rats. Inflammation . 2004;28:327-336. (Pubitemid 41504276)
20. Hagio T, Matsumoto S, Nakao S, et al. Sivelestat, a specific neutrophil elastase inhibitor, prevented phorbol myristate acetate-induced acute lung injury in conscious rabbits. Pulm Pharmacol Ther. 2005;18:285-290. (Pubitemid 40379751)
21. Fujimura N, Obara H, Suda K, et al. Neutrophil elastase inhibitor improves survival rate after ischemia-reperfusion injury caused by supravisceral aortic clamping in rats. J Surg Res. 2012;180:31-36.
22. Uchida Y, FreitasMC, Zhao D, BusuttilRW,Kupiec-Weglinski JW. The inhibition of neutrophil elastase amelioratesmouse liver damage due to ischemia and reperfusion. Liver Transpl. 2009;15:939-947.
23. Yoshida N, Granger DN, Anderson DC, Rothlein R, Lane C, Kvietys PR. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol. 1992;262:1891-1898.
24. Shapiro SD, Campbell EJ, Senior RM, Welgus HG. Proteinases secreted by human mononuclear phagocytes. J Rheumatol Suppl. 1991;27:95-98.
25. Rainger GE, Rowley AF, Nash GB. Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: specificity of different chemotactic agents. Blood. 1998;92: 4819-4827. (Pubitemid 29005885)
26. Houston DS, Carson CW, Esmon CT. Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor release and augment neutrophil elastase release. J Biol Chem. 1997;272:11778-11785. (Pubitemid 27202744)
27. Sue-A-Quan AK, Fialkow L, Vlahos CJ, et al. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases. J Cell Physiol . 1997;172:94-108. (Pubitemid 27283352)
28. Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med. 2001;164:896-904. (Pubitemid 32881931)
29. Harlan JM. Leukocyte-endothelial interactions. Blood. 1985;65:513-525.
30. Sallenave J-M, Donnelly SC, Grant IS, Robertson C, Gauldie J, Haslett C. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J. 1999;13:1029-1036. (Pubitemid 29288925)
31. Wewers MD, Herzyk DJ, Gadek JE. Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J Clin Invest. 1988;82:1260-1267.
32. Rice WG, Weiss SJ. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science. 1990;249:178-181.
33. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376. (Pubitemid 19106873)
34. Boudier C, Bieth JG. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor. Biochem J. 1994;303:61-68. (Pubitemid 24302900)
35. Morrison HM, Welgus HG, Stockley RA, Burnett D, Campbell EJ. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. Am J Respir Cell Mol Biol . 1990;2:263-269.
36. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell surface-bound elastase and cathepsin G on human neutrophils. A novel, non-oxidative mechanism by which neutrophils focus and pre-serve catalytic activity of serine proteinases. J Cell Biol . 1995;131:775-789.
37. Essani NA, Fisher MA, Farhood A, et al. Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology. 1995;21:1632-1639.
38. Essani NA, Bajt ML, Vonderfecht SL, et al. Transcriptional activation of vascular cell adhesion molecule-1 (VCAM-1) gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol . 1997;158:5941-5948. (Pubitemid 127484003)
39. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5:1317-1327. (Pubitemid 37410245)
40. LiX K, Matin AFM, Suzuki H, et al. Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation. 1993;56:1331-1336.
41. Okuhama Y, Shiraishi M, Higa T, et al. Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res. 1999;82:34-42. (Pubitemid 29394150)
42. Jung SE, Yun IJ, Youn YK, et al. Effect of protease inhibitor on ischemia-reperfusion injury to rat liver. World J Surg. 1999;23:1027-1031.
43. Harada N, Okajima K, Kushimoto S. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med. 1999;27:1958-1964. (Pubitemid 29455131)
44. Ishihara K, Yamaguchi Y, et al. ICAM-1 signal transduction in cell stimulated with neutrophil elastase. Dig Dis Sci. 2006;51:2102-2112. (Pubitemid 44832598)
45. Kawahara Y, Ninomiyz I, et al. Prospective randomised controlled study on the effect of perioperative administration of a neutrophil elastase inhibitor to patient undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23:329-339.